News Features Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019 Todd Neale December 10, 2019
News Conference News TCT 2019 Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk Michael O'Riordan September 29, 2019
News Industry News Neovasc Provides Further Update on Reducer™ Program for Treatment of Refractory Angina July 16, 2019
News Daily News TAVR Growing in the US, but Vast Majority of Patients Not Receiving Any Form of Valve Replacement Michael O'Riordan June 12, 2019
News Industry News Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™ May 06, 2019
News Industry News Neovasc Announces Peer Reviewed Publication in the International Journal of Cardiology Demonstrating that the Neovasc Reducer™ Improves Diastolic Function in patients suffering from severe angina April 17, 2019
News Conference News ACC 2019 COAPT Quality-of-Life Analysis Points to Significant, Sustained Benefits in Health Status With MitraClip Shelley Wood March 17, 2019
News Conference News TEST - COAPT Quality-of-Life Analysis Points to Significant, Sustained Benefits in Health Status With MitraClip Shelley Wood April 10, 2001